[1]
L. Khan, M. A. Salsabil, J. Ferdous, and M. R. Haque, “Evaluation of Myelosupression during Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukaemia”, J. Armed Forces Med. Coll., vol. 15, no. 2, pp. 189–192, Dec. 2020.